Vacancy: Post-doc Scientist
Molecular biology / Biochemistry/Immuno-Oncology field
AIMM Therapeutics BV is an Amsterdam based biotech company that develops human monoclonal antibodies for the treatment of cancer. AIMM was established fifteen years ago on the belief that the power of specific immune cells could be harnessed to develop clinically relevant antibody therapies while avoiding the inefficiencies inherent to other techniques. AIMM has developed an efficient platform to generate human monoclonal antibodies. Today this proprietary platform technology is well validated as evidenced by the striking success of a phase 2b trial of one antibody discovered by AIMM which has met its primary endpoint, and the deep pipeline of therapeutic antibodies that AIMM is currently advancing in cancer.
We have an opportunity for a highly motivated and experienced scientist to strengthen our team. The candidate will be involved in discovery and biochemical characterization of novel therapeutic antibodies for treatment of cancer. The ideal candidate will have a proven track-record in biochemistry and immunology and in the application of novel biochemical and molecular biology technologies for solving complex biological problems. He/she should have a broad understanding of and experience with next generation sequencing, immune repertoire profiling and their applications.
A post-doctoral researcher with at least 4 years’ experience in molecular biology, biochemistry, in structural biology of macromolecular protein complexes; gene structures, cell biology or immunology, and characterization of large macromolecular protein complexes for structural analysis. The candidate should have proven ability to independently perform scientific and/or development experiments; identifies and selects problems to be studied to strengthen the strategy of AIMM; develops and troubleshoots new experimental techniques and protocols.
Education and Experience
Effective communication skills in English and the ability to successfully operate in a multifunctional team are essential.
The appointment with AIMM Therapeutics BV will initially be for 12 months, with prospects for a permanent position being dependent on the progress made within the project and on developments within the company. Salary is commensurate with position and experience.
More information about the position can be obtained from Hergen Spits (firstname.lastname@example.org). Please send your application in English together with CV and names of preferably three references (including email address and phone number) before March 16, 2019 to: email@example.com, regular mail: AIMM Therapeutics BV, Meibergdreef 59, 1105 BA, Amsterdam.